Home

Produkte

Goodsell David S.Richman Douglas D.

The Future of HIV-1 Therapeutics

Resistance Is Futile?

AutorGoodsell David S.Richman Douglas D.
QuelleSonstige Datenquellen
ISBN978-3-319-18517-0
Lieferbarkeitlieferbar
KatalogisatBasiskatalogisat
VerlagSpringer International Publishing
Erscheinungsdatum06.05.2015
Buch | Gebunden
106,99 €
inkl. 7% MwSt.

Beschreibung (Langtext)

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.


Weitere Titel wie 'The Future of HIV-1 Therapeutics'

General pathology student guide
Buch | Kartoniert
32,09 €
inkl. 7% MwSt.
Computational Virology
Buch | Gebunden
192,59 €
inkl. 7% MwSt.
Epizootic Hemorrhagic Disease Virus
Buch | Gebunden
235,39 €
inkl. 7% MwSt.
Graft-Versus-Host Disease
Buch | Gebunden
299,59 €
inkl. 7% MwSt.